Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724873 | SCV000230070 | uncertain significance | not provided | 2015-06-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724873 | SCV000526746 | uncertain significance | not provided | 2023-12-28 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |
Labcorp Genetics |
RCV001079340 | SCV000658589 | benign | Familial hyperkalemic periodic paralysis | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000724873 | SCV003821321 | uncertain significance | not provided | 2023-06-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004537458 | SCV004754481 | likely benign | SCN4A-related disorder | 2019-12-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |